184151-07-3 Usage
Uses
Used in Pharmaceutical Industry:
Benzoic acid, 3-(acetylamino)-2-hydroxy-, methyl ester (9CI) is used as a key intermediate compound for the synthesis of various pharmaceutical compounds, particularly sphingosine kinase inhibitors. These inhibitors play a crucial role in the development of novel therapeutics for the treatment of cancer and other diseases.
In the preparation of sphingosine kinase inhibitors, the compound serves as a building block, contributing to the overall structure and activity of the final product. The acetylamino and hydroxyl functional groups in the molecule allow for further chemical modifications and the formation of a diverse range of biologically active compounds with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 184151-07-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,4,1,5 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 184151-07:
(8*1)+(7*8)+(6*4)+(5*1)+(4*5)+(3*1)+(2*0)+(1*7)=123
123 % 10 = 3
So 184151-07-3 is a valid CAS Registry Number.
184151-07-3Relevant articles and documents
CONDENSED BENZAMIDE COMPOUNDS AND INHIBITORS OF VANILLOID RECEPTOR SUBTYPE 1 (VR1) ACTIVITY
-
Page/Page column 42, (2010/11/28)
To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain
Indole derivatives as cGMP-PDE inhibitors
-
, (2008/06/13)
Compounds of the formula (I): STR1 and their pharmaceutically acceptable compositions are useful in inhibiting the activity of cyclic guanosine 3',5'-monophosphate phosphodiesterase.
